首页> 外国专利> A method for manufacturing intrascleral implant for the sustained release of triamcinolone acetonide and intrascleral implant manufactured from this method

A method for manufacturing intrascleral implant for the sustained release of triamcinolone acetonide and intrascleral implant manufactured from this method

机译:一种用于曲安奈德缓释的巩膜内植入物的制造方法以及由该方法制造的巩膜内植入物

摘要

An intrascleral implant for the sustained release of triamcinolone acetonide is provided, which uses the double film biodegradable PLA(Poly(D,L-lactide)). An intrascleral implant for the sustained release of triamcinolone acetonide is constituted as follows. The triamcinolone acetonide is continuously released within sclera by using the biodegradable double film matrix separator. Serious complication and repetitive injection which are the disadvantage of the glass internal TA injection are complemented. The extended release of drug and drug delivery effect of focalization are improved. By forming the biodegradable double film matrix separator, the concentration of the drug in the eyeball is maintained by the specified level after 3 months.
机译:提供了一种用于持续释放曲安奈德丙酮酸酯的巩膜内植入物,该植入物使用了双层可生物降解的PLA(聚(D,L-丙交酯))。用于持续释放曲安奈德丙酮酸酯的巩膜内植入物如下构成。通过使用可生物降解的双层膜基质分离器,曲安奈德丙酮化物在巩膜内连续释放。严重的并发症和重复注射是玻璃内部TA注射的缺点。延长了药物的释放和集中的给药效果。通过形成可生物降解的双层膜基质分离器,眼球中药物的浓度在3个月后保持在指定水平。

著录项

  • 公开/公告号KR100895840B1

    专利类型

  • 公开/公告日2009-05-06

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20070063566

  • 发明设计人 김시열;신재필;김유미;임정옥;

    申请日2007-06-27

  • 分类号A61F9/007;A61F9;A61F2/14;

  • 国家 KR

  • 入库时间 2022-08-21 19:12:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号